Log In
Print
BCIQ
Print
Print this Print this
 

Anti-TWEAK (TWEAK inhibitor) (BIIB023)

  Manage Alerts
Collapse Summary General Information
Company Biogen Idec Inc.
DescriptionHumanized mAb against tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK)
Molecular Target TNF-like weak inducer of apoptosis (TWEAK)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationLupus
Indication DetailsTreat lupus nephritis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today